To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

The Evo2 genomic language model can generate short genome sequences, but scientists say further advances are needed to write ...

See how anyone can build a working app or website in minutes — no coding skills required.

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Why Tiny Downloads Matter Again Modern web games can be massive, but the fastest experiences still start with a small download. A 13KB limit is famous because it forces a game to load almost instantly ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Looking for ways to make some extra money this year? We've compiled a list of different passive income ideas to spark inspiration, including investing, real estate and a few niche options, like ...

This program is created solely for educational purposes. Any misuse of this program for illegal activities is not condoned and is beyond the responsibility of the creator. Contributions are welcome!

Digital retail finance, personal finance and payments industry which offers access to point of sale credit and digital payment services, connecting customers with its network of merchants and offers ...

Generate is indicative of a more mature startup that may have a better chance of succeeding in today’s markets. Industry IPOs peaked in 2021, resulting in a flood of companies whose early science didn ...